Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course

Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients

(2021) Ioannis Ilias et al.   Medicina-Lithuania

COVID-19 and the liver: an adverse outcome pathway perspective

(2021) Mathieu Vinken   TOXICOLOGY

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

(2020) Yijin Wang et al.   JOURNAL OF HEPATOLOGY

COVID-19: Abnormal liver function tests

(2020) Qingxian Cai et al.   JOURNAL OF HEPATOLOGY

Liver tests abnormalities in COVID-19: trick or treat?

(2020) Edoardo Vespa et al.   JOURNAL OF HEPATOLOGY

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

(2020) Alfonso J. Rodriguez-Morales et al.   Travel Medicine and Infectious Disease

Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression

(2020) Xiongfeng Pan et al.   International Journal of Environmental Research and Public Health

COVID-19, MERS and SARS with Concomitant Liver Injury—Systematic Review of the Existing Literature

(2020) Michał Kukla et al.   Journal of Clinical Medicine

Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?

(2020) Francis M. Finucane et al.   Frontiers in Public Health

The clinical manifestations and management of COVID-19-related liver injury

(2020) Tung-Hung Su et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19

(2020) Jiao-Feng Huang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

(2020) Kenneth I. Zheng et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?

(2020) Mauricio Krause et al.   Diabetology & Metabolic Syndrome

Factors Leading to High Morbidity and Mortality of COVID ‐19 in Patients with Type 2 Diabetes

(2020) Aman Rajpal et al.   Journal of Diabetes

COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella

(2020) Geoffroy Méry et al.   Frontiers in Immunology

Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture

(2020) Miriane de Oliveira et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Etiology and management of liver injury in patients with COVID-19

(2020) Rui-Xu Yang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19

(2020) Saima Ajaz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

(2020) Enrico Brunetta et al.   NATURE IMMUNOLOGY

Visceral fat is associated to the severity of COVID-19

(2020) Guillaume Favre et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study

(2019) Lizhi Tang et al.   BMC Endocrine Disorders

PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

(2018) Cecilia Garlanda et al.   PHYSIOLOGICAL REVIEWS

Are Fetuin-A levels beneficial for estimating timing of sepsis occurrence?

(2018) Hatice Altinisik et al.   SAUDI MEDICAL JOURNAL

Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population

(2017) Zhengsen Cui et al.   Oncotarget

Decreased Serum Fetuin-A Levels and Active Inflammatory Bowel Disease

(2014) Peng Ma et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention

(2012) Sang Hui Chu et al.   CLINICA CHIMICA ACTA

Fetuin-A is Associated with Disease Severity and Exacerbation Frequency in Patients with COPD

(2012) Markos Minas et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Anti-Inflammatory Role of Fetuin-A in Injury and Infection

(2012) H. Wang et al.   CURRENT MOLECULAR MEDICINE

Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey

(2011) J. Jylhävä et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation

(2011) Wei Li et al.   PLoS One

Fetuin-A and Cystatin C Are Endogenous Inhibitors of Human Meprin Metalloproteases

(2010) Jana Hedrich et al.   BIOCHEMISTRY

Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients

(2010) Amal M. El-Shehaby et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells

(2008) Giuseppe Danilo Norata et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY